Comparison Bioequivalence Study: Pre-filled Syringe (Reference) Versus Auto-injection Device (Test)

PHASE1CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Healthy
Interventions
DRUG

Certolizumab pegol

Auto-injection device (test) containing 1 mL of certolizumab pegol liquid formulation, 200 mg/mL; 2 injections

DRUG

Certolizumab pegol

Pre-filled syringe (reference) containing 1 mL of certolizumab pegol liquid formulation, 200 mg/mL; 2 injections

Trial Locations (1)

Unknown

Rennes

Sponsors

Lead Sponsor

All Listed Sponsors
lead

UCB Pharma

INDUSTRY